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to the possibility of induced artifacts or loss of information 
that we observed, a visual comparison of each MAR scan with 
the original scan is performed, and the HU values in the 
artifact-reduced area are spot checked for reasonability 
relative to known tissue HU values. Future studies will 
investigate the impact of this type of MAR on contouring 
variability and accuracy. 
 
 
 
Figure 1: Example of a plan for a patient with bladder cancer 
and double hip prostheses without (top) and with (bottom) 
MAR, where the PTV identical in both images (colorwash 15-
68 Gy). In the top image, the dose was calculated after 
manual override of artifact to 0 HU. The mean dose to the 
PTV was 63.8 Gy and 64.0 Gy, respectively. 
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Purpose or Objective: To assess the dosimetric accuracy of 
CT-substitute attenuation correction (AC) maps generated 
from existent clinical MR data for radiation treatment 
planning in glioma patients. 
 
Material and Methods: CT substitute AC maps were obtained 
with Statistical Parametric Software (SPM) software applied 
on 3D T1-weighted Inversion Recovery scans (IT 650 ms; 
TR/TE 4.6/2.0 ms). Three probability maps (PM) were 
obtained: air, tissue and bone. To derive corresponding AC 
maps, air-PM was multiplied by -1000, tissue-PM by 30 and 
bone-PM by 1000 and 300 when the probability for bone 
tissue was >0.8 and <0.8, respectively. A composite AC map 
(MR-based CT) was obtained by summing up all the PM 
multiplied by the aforementioned values. Difference in bone 
between clinical CT and MR-based CT was quantified with the 
Dice Similarity Coefficient (DSC). 
MR-based CT were read into Eclipse Treatment Planning 
System (Varian Medical Systems, Palo Alto CA) and clinical 
Volumetric Modulated Arc Therapy (VMAT) plans were 
recalculated with a 0.1 cm dose calculation grid size for 10 
patients. All plans were calculated with Accuros XB dose 
calculation algorithm for a prescription dose of 60 Gy and 
consisted of two arcs with a different collimator angle to 
minimize tongue and groove effect. 
Differences between both plans were assessed according to 
the D2%, D98%, Dmean and γ-index (3%/3mm) for the 
relevant structures: CTV, PTV, brainstem and optical system. 
 
Results: MR-based CTs were generated for 10 patients using 
SPM software and current clinical MR examinations without 
the need of adding extra sequences to the clinical protocol. 
Bone segmentation exhibited an average DSC of 0.81±0.07 
(SD) between clinical CT and MR-based CT segmentation, 
detecting SPM software less bone than in the clinical CT. 
Recalculated VMAT plans on the MR-based CTs exhibited a 
very good agreement with the clinical plans. Average Dmean, 
D2% and D98% for CTV and PTV differed less than 0.5%. 
Difference in D2% for brainstem and optical system between 
the clinical plans and recalculated plans using an MR-based 
CT were 0.4% and 1.1%, respectively. All metrics were found 
not significantly different (p>0.05) from the clinically 
approved plans. 
3D-dose distributions for the CTV and PTV in MR-based plans 
resulted in γ-passing rates higher than 0.99±0.01 for both 
structures. Average γ-value for CTV and PTV was 0.16±0.08 
and 0.23±0.16, respectively. 
 
Conclusion: MR-based CTs were generated using SPM 
software on 3D MR T1-weighted Inversion Recovery scans with 
more than 80% agreement for bone segmentation. MR-based 
VMAT plans exhibited a very good agreement with the clinical 
plans based on a standard CT as measured by the D2%, D98%, 
Dmean and γ-index metrics for all relevant structures. 
It is feasible a clinical workflow for radiation treatment 
planning purposes for glioma patients based only on MR 
without the need of CT or adding additional MR sequences to 
the clinical protocol for bone segmentation. 
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Purpose or Objective: Current clinical practise in 
radiotherapy CT scanning of lung tumours takes into account 
movement due to breathing. However, the accuracy of used 
scan protocols is usually validated for phantoms with fairly 
regular movements, and the effects of breathing irregularity 
are unclear. Aim of this study is to establish the impact of 
clinically occurring irregularities on delineated treatment 
volumes determined using 4DCT images. 
 
Material and Methods: Respiratory patterns, as recorded 
during CT scanning, were (anonymously) obtained for 50 lung 
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ca. patients treated in our institution. First, pattern statistics 
were compared to population data in literature to establish 
validity of the data used for testing. Second, patterns 
representing highest irregularity were selected: variance in 
amplitude (1), periodicity (2), and a pattern with a baseline 
drift (3). A periodical computer generated sinusoid (4) was 
used for comparison.  
Patterns were fed into a QUASAR™ Respiratory Motion 
Phantom (Modus Medical), with “lung tumour insert” 
(cork/polystyrene). Each pattern was scanned 5 times using a 
16 slice lightspeed RT series scanner (General Electric). 
“Lung tumour” contours were extracted using auto 
segmentation of average (AVE) and MIP CT data. Contour 
volumes were compared using Dice coefficients (DC) and to 
expected volumes. 
 
Results: The average breathing amplitude in our patient 
population was 8.70± 3.0 mm. The average period was 3.99 ± 
1.0 seconds per breath. Both compared well with literature 
values.  
Based on repeat CT data, DC was ≥ 0.90 for group ( 1) and (3) 
and (4). However, DC for group 2 (‘irregular periodicity), was 
only 0.83, which is significantly lower (p=0.002). Computed 
volumes were nearer to expected volumes using AVE CT, but 
using AVE CT always leads to underestimation. Volumes 
computed in MIP CT reconstructions cover the expected 
volumes better, but there is a chance of overestimation of up 
to 20% in volume. 
 
Conclusion: Even though 4D CT scanning has been around 
quite some time, this is one of the first studies to address the 
effects of clinically found breathing irregularities. The 
selected test data seem to be adequate for lung ca. patients, 
and selected types of irregularities are commonly seen by 
therapists operating CT scanner and linac. 
The study indicates that irregular respiratory patterns 
introduce the element of “chance” in the position and size of 
delineated tumour volumes, depending on amount and type 
of irregularity. Therefore, it is recommended to always take 
into account effect of breathing pattern irregularity in 
scanning and treatment planning for lung tumours. 
Since 4D imaging typically consists of scanning while tracking 
a marker position, the recommendation probably holds for 
every CT scanner used in radiotherapy, and possibly also for 
PET and MRI scanners. 
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Purpose or Objective: Most institutes use the ITV approach 
to account for breathing motion into treatment planning, 
generally yielding too large treatment volumes. Recent 
publications showed that use of a mid-ventilation CT (midV-
CT, representing the mean breathing phase) and treating 
remaining breathing motions as a random error, led to high 
tumor control and overall survival for hypo-fractionated 
treatments. However, the midV-CT is not available 
commercially yet. In this work we perform a marker-based 
validation of our open-source software to generate a midV-CT 
for upper abdomen cancer patients. 
 
Material and Methods: Planning data from 12 upper 
abdominal cancer patients (8 liver- and 4 pancreatic 
patients) were used for this study. These patients were 
treated with the ITV approach using hypo-fractionated 
schemes (ranging from 5x7.5 Gy to 1x24 Gy). Each patient 
had a gold marker implanted close to the CTV center of mass 
(COM). 4DCT data consisted of 10 amplitude-based breathing 
phases (CT BrillianceTM, Phillips). In our planning system 
(EclipseTM,Varian), the position of the marker was measured 
by hand for each breathing phase and patient. In the open- 
source medical imaging 3DSlicer, B-spline deformable 
registration was used to register the plan CT and the 
different phases of the 4DCT. The resulting transformation 
matrices were then used by our 3DSlicer modules to 
automatically generate the midV-CT and the COM motions of 
any planning volume or marker. Subsequently, the marker 
position in the midV-CT was compared to the average marker 
position in Eclipse. Furthermore, the Eclipse marker motion 
curves and amplitudes were compared with the marker and 
CTV motions from 3DSlicer. Additionally, treatments plans 
were generated for one patient using the midV-CT and 
compared with our ITV-based clinical plan. 
 
Results: The mean CTV volume was 24.7±22.0 cc (1SD) and 
the mean marker to CTV COM distance was 12.7±6.2mm 
(1SD). The midV CTs are generated by 3DSlicer within 30 
minutes using a PC. Motion validation results are shown in 
Table 1. Differences in the mean COM of the marker in 
Eclipse and in midV-CT are within 1 mm, indicating an 
accurate midV-CT generation by our software. Average 
amplitude differences are within 1 mm but Eclipse motions 
tend to be slightly larger, possibly due to the uncertainty of 
manually finding the marker in the 4D phases. 
Correspondingly, RMS differences between motion curves of 
Eclipse and 3DSlicer were therefore 0.2-0.6 mm, whereas the 
RMS differences between marker and CTV motion in 3DSlicer 
only 0.1-0.2 mm (Fig 1a). The latter suggests that well-
placed markers can estimate CTV motions. Fig 1b shows 
differences in dose volume histograms between the ITV and 
the midV-CT approach. 
 
 
 
